Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 
 
Prospectus synopsis
 
Park Medi World Ltd
Registered Office: No.12 Meera Enclave , Outer Ring Road , New Delhi - 110018 , Delhi , India.
Phone:+91 124 696 0000   Fax:
Email: company.secretary@parkhospital.in   Website:www.parkhospital.in
Initial public offer of up to [*] equity shares of face value of Rs. 2/- each ("Equity Shares") of Park Medi World Limited ("Company") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) ("Offer Price") aggregating up to Rs. 920.00 crores comprising a fresh issue of up to [*] equity shares of face value of Rs. 2/- each aggregating up to Rs. 770.00 crores by the company ("Fresh Issue") and an offer for sale of up to [*] equity shares of face value of Rs. 2/- each aggregating up to Rs. 150.00 crores ("Offered Shares") by Ajit Gupta ("the Promoter Selling Shareholder") ("Offer for Sale", and together with the fresh issue, the "Offer"). The company, in consultation with the brlms, may consider an issue of specified securities, as may be permitted under applicable law, aggregating up to Rs. 192.00 crores prior to filing of the ("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. The pre-ipo placement, if undertaken, shall not exceed 20 % of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if Undertaken). The face value of equity shares is Rs. 2/- each. The offer price is [*] times the face value of the equity shares. Price Band: Rs. 154 to Rs. 162 per equity share of face value of Rs. 2 each. The floor price is 77 times of the face value and the cap price is 81 times of the face value of the equity shares. Bids can be made for a minimum of 92 equity shares and in multiples of 92 equity shares thereafter.

Issue
Money Payable On
Opens On
Closes On
Application
Allotment
10-Dec-25 12-Dec-25 Rs 154.00-162.00 Rs 0.00-0.00
Minimum Application for shares in Nos : 92   Further Multiples of : 92


 
Rs Cr
Lead Managers to the Issue
Project Cost 0.00
CLSA India Pvt ltd
DAM Capital Advisors Ltd
Intensive Fiscal Services Pvt Ltd
Nuvama Wealth Management Ltd
Project Financed through Current Offer 920.00  
Post Issue Equity Share Capital 86.39  
Issue Price Rs.154.00  
 
Projects
Repayment/Prepayment in full or in part of certain outstanding borrowings availed by the company and certain of the company subsidiaries Funding capital expenditure for development of new hospital by its Subsidiary Park Medicity (NCR)
Funding capital expenditure for purchase of medical equipment by the Company and its Subsidiaries, Blue Heavens and Ratangiri General corporate purposes
Promoted By
Listing At
Registrar to the Issue
 
 < Back Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView